TipRanks
Go Ultimate55% OFF

Hemab Therapeutics Holdings, Inc. (COAG) Income Statement

Hemab Therapeutics Holdings, Inc. Income Statement

Last quarter (Q2 2026), Hemab Therapeutics Holdings, Inc.'s total revenue was $0.00. In Q2, Hemab Therapeutics Holdings, Inc.'s net income was $-24.15M. See Hemab Therapeutics Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25
$ 0.00
$ 0.00
$ 70.12M
Depreciation and Amortization$ 304.00K
$ -69.81M
$ -70.12M
$ 5.98M
$ -64.14M
$ -63.91M
Per Share Metrics
Basic EPS$ -2.33
Diluted EPS$ -2.33
Weighted Average Shares Outstanding27.44M
Weighted Average Shares Outstanding (Diluted)27.44M

Currency in USD

Hemab Therapeutics Holdings, Inc. Earnings and Revenue History

-75M-50M-25M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2025RevenueEarningsProfit Margin